Proenkephalin+ regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function. 2020

Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
Department of Immunology, Nagoya City University Graduate School of Medical Sciences, 467-8601 Nagoya, Japan.

Regulatory T (Treg) cells, expressing CD25 (interleukin-2 receptor α chain) and Foxp3 transcription factor, maintain immunological self-tolerance and suppress various immune responses. Here we report a feature of skin Treg cells expanded by ultraviolet B (UVB) exposure. We found that skin Treg cells possessing a healing function are expanded by UVB exposure with the expression of an endogenous opioid precursor, proenkephalin (PENK). Upon UVB exposure, skin Treg cells were expanded with a unique TCR repertoire. Also, they highly expressed a distinctive set of genes enriched in "wound healing involved in inflammatory responses" and the "neuropeptide signaling pathway," as indicated by the high expression of Penk. We found that not only was PENK expression at the protein level detected in the UVB-expanded skin Treg (UVB-skin Treg) cells, but that a PENK-derived neuropeptide, methionine enkephalin (Met-ENK), from Treg cells promoted the outgrowth of epidermal keratinocytes in an ex vivo skin explant assay. Notably, UVB-skin Treg cells also promoted wound healing in an in vivo wound closure assay. In addition, UVB-skin Treg cells produced amphiregulin (AREG), which plays a key role in Treg-mediated tissue repair. Identification of a unique function of PENK+ UVB-skin Treg cells provides a mechanism for maintaining skin homeostasis.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011498 Protein Precursors Precursors, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004744 Enkephalin, Methionine One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Methionine Enkephalin,5-Methionine Enkephalin,Met(5)-Enkephalin,Met-Enkephalin,5 Methionine Enkephalin,Enkephalin, 5-Methionine,Met Enkephalin
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D005260 Female Females
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
December 2014, Journal of immunology (Baltimore, Md. : 1950),
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
July 2008, The Journal of experimental medicine,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
January 2019, Nature communications,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
November 2010, Immunity,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
May 2012, Immunity,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
March 2016, Proceedings of the National Academy of Sciences of the United States of America,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
December 2017, Nature communications,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
January 2019, Science immunology,
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
November 2020, Journal of immunology (Baltimore, Md. : 1950),
Hiroaki Shime, and Mizuyu Odanaka, and Makoto Tsuiji, and Takuma Matoba, and Masaki Imai, and Yoshiaki Yasumizu, and Ryuta Uraki, and Kiyoshi Minohara, and Maiko Watanabe, and Anthony John Bonito, and Hidehiro Fukuyama, and Naganari Ohkura, and Shimon Sakaguchi, and Akimichi Morita, and Sayuri Yamazaki
October 2023, Military Medical Research,
Copied contents to your clipboard!